Subscription Update for Pharmaceutical Companies
Jinfo Blog
8th April 2015
Abstract
The driving force for companies in the pharmaceutical space is optimal management of the drug pipeline. Acquiring accurate and timely information about the lifecycle of specific drugs, and making that information visible throughout the organisation, is crucial to this process. Pharmaceutical companies will find resources with direct relevance to both aspects of these topics in recent FreePint Content and Community events. We also share information on recent Consulting projects with pharmaceutical companies.
Item
Content (Articles, Reports and Webinars)
An important new resource to aid evaluation of drug information services is now available to FreePint subscribers in a comprehensive, nine-part product review of AdisInsight. The product review goes into detail on the content coverage for trials, drugs and safety provided by AdisInsight, as well as reviewing platform features and technology, and the competitive landscape for each content area. This report will be of value for working with stakeholders throughout the organisation.
Information managers in pharmaceutical companies are also interested in assessing and improving discoverability of content across the enterprise. In the first three months of 2015, FreePint has been conducting research and events on this topic, generating a wealth of information now available under the FreePint Topic Series "Making Information Visible". The three main themes have emerged: the right technology, the right content and the right user behaviour.
- In the context of enabling technology, Robin Neidorf discusses tools and technologies, including analytics and visualisation, which aid in making information more accessible. A webinar session explored how organisations choose a discovery service (recording available) and Sophie Alexander summarises the event in her article "Case Studies - Selecting a Discovery Solution". Another article assesses why enterprise search will never be like Google
- Assessing content considerations, one article addresses blending internal and external content and Robin Neidorf rounds out the content perspective derived from the research
- From the lens of user needs and behaviour, Sean Smith kicks off the discussion of effective user engagement, Nigel Wiliams points out the dangers of not appealing to your audience, and Steve Bynghall puts users at the centre of discovery.
During this same time period, FreePint initiated research on another timely topic, the use of ebooks in enterprise settings. Pharmaceutical companies were one of the largest market segments responding to the survey, and the sector has some of the highest levels of penetration for ebook usage. Look for the details of the FreePint survey results to be published soon.
Updates on content providers of interest to R&D-intensive organisations include an interview with EBSCO's VP of user research and with the chief sales and marketing officer at Reprints Desk.
Community
The discussion about information visibility is still continuing and you can join a live workshop about needs assessment coming up in April. Register for the in-person meeting in Minneapolis on 15th April here (13:30 Central) or for the live phone conversation on 16th April here.
Another event for information buyers focused on the perspectives and needs of stakeholders in organisations dealing with tangible goods (as opposed to professional services or consulting).
Consulting
We're delighted to be working with another pharmaceutical company on strategic planning, this time exploring the skills that information professionals will need to cultivate to be successful in the future, and then analysing existing competencies to identify gaps.
It's a great honour to partner with an organisation in this way, and it fits in beautifully with our research and development in the current Topic Series, "Best Practices in Information Skills Development".
A FreePint Subscription at the Content level gives access to all FreePint articles, reports and webinars, at the Community level gives access to all FreePint Communities of Practice (as well as all FreePint Content), and at the Consulting level adds a credit for up to six hours of annual consulting time. Find out more.
- Blog post title: Subscription Update for Pharmaceutical Companies
- Link to this page
- View printable version
Discussing news and AI strategies with the Financial Times
Community session
21st November 2024
2025 strategic planning; evaluating research reports; The Financial Times, news and AI
Blog posting
5th November 2024
November 2024 Update
YouTube video
7th November 2024
- 2025 strategic planning; evaluating research reports; The Financial Times, news and AI
5th November 2024 - All recent Jinfo Subscription content
31st October 2024 - End-user training best practice research
24th October 2024
- Jinfo Community session (TBC) (Community) 11th December 2024
- Discussing news and AI strategies with the Financial Times (Community) 21st November 2024
- Asia-Pacific Community session (Community) 19th November 2024